The Brazilian Ministry of Health signed on Friday, 19, the purchase of 138 million doses of COVID-19 vaccine. Of these, 100 million are from Pfizer and 38 million are from Janssen (produced by Johnson & Johnson).
The Government’s schedule predicts that doses will arrive in batches: 13.5 million doses from Pfizer in the second quarter and 86.4 million by September; 16.9 million doses of Janssen are expected to arrive between July and September and 21.1 million between October and December.
However, the Ministry of Health reported that the delivery schedule may change depending on the availability of doses by suppliers.
According to a report on the G1 website, the contract with Pfizer will cost $ 1 billion and with Janssen, $ 388 million.
So far, only the Pfizer and AstraZeneca/Oxford vaccines (which are produced in Brazil by the Oswaldo Cruz Foundation) are authorized for permanent use by the Brazilian health regulator Anvisa. The Janssen vaccine is not even authorized for emergency use.